Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II

Clinical trial NCT05702463 · RECRUITING

Trial details

NCT number: NCT05702463
Sponsor: Montreal Heart Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Platelet Aggregation Type 2 Diabetes Aspirin Diabetes Mellitus, Type 2 Platelet Aggregation Inhibitors

Start date: 2023-06-13
Primary completion: 2027-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.